Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal pigment epithelial cell | 4 studies | 57% ± 16% | |
adipocyte | 3 studies | 47% ± 13% |
Insufficient scRNA-seq data for expression of RDH5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 674.13 | 89 / 89 | 83% | 4.30 | 748 / 901 |
liver | 99% | 1976.58 | 224 / 226 | 76% | 3.27 | 310 / 406 |
ovary | 97% | 418.64 | 175 / 180 | 69% | 2.47 | 298 / 430 |
thymus | 97% | 493.40 | 634 / 653 | 68% | 3.23 | 414 / 605 |
intestine | 100% | 1228.28 | 966 / 966 | 55% | 1.07 | 290 / 527 |
stomach | 89% | 497.62 | 321 / 359 | 55% | 1.15 | 158 / 286 |
skin | 93% | 461.73 | 1676 / 1809 | 40% | 1.59 | 187 / 472 |
esophagus | 95% | 730.69 | 1367 / 1445 | 37% | 0.68 | 67 / 183 |
bladder | 95% | 635.38 | 20 / 21 | 23% | 0.44 | 117 / 504 |
uterus | 98% | 492.86 | 166 / 170 | 20% | 0.54 | 91 / 459 |
breast | 100% | 2568.98 | 457 / 459 | 18% | 0.38 | 200 / 1118 |
brain | 63% | 192.72 | 1653 / 2642 | 52% | 1.42 | 364 / 705 |
prostate | 98% | 661.96 | 240 / 245 | 14% | 0.20 | 69 / 502 |
lung | 85% | 303.79 | 490 / 578 | 19% | 0.35 | 219 / 1155 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.16 | 1 / 1 |
adipose | 100% | 3655.83 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1111.49 | 1333 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 593.82 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 96% | 889.66 | 827 / 861 | 0% | 0 | 0 / 0 |
muscle | 88% | 447.79 | 707 / 803 | 0% | 0 | 0 / 0 |
pancreas | 26% | 64.44 | 85 / 328 | 54% | 1.09 | 96 / 178 |
adrenal gland | 71% | 233.92 | 183 / 258 | 4% | 0.07 | 9 / 230 |
peripheral blood | 60% | 224.28 | 558 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.27 | 6 / 29 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.19 | 4 / 45 |
eye | 0% | 0 | 0 / 0 | 5% | 0.54 | 4 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007601 | Biological process | visual perception |
GO_0001523 | Biological process | retinoid metabolic process |
GO_0008202 | Biological process | steroid metabolic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0044297 | Cellular component | cell body |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004745 | Molecular function | all-trans-retinol dehydrogenase (NAD+) activity |
GO_0047044 | Molecular function | androstan-3-alpha,17-beta-diol dehydrogenase activity |
GO_0106429 | Molecular function | 11-cis-retinol dehydrogenase |
GO_0047023 | Molecular function | androsterone dehydrogenase activity |
Gene name | RDH5 |
Protein name | Retinol dehydrogenase 5 Retinol dehydrogenase 5 (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (11-cis retinol dehydrogenase) (11-cis RDH) (11-cis RoDH) (9-cis retinol dehydrogenase) (9cRDH) (Short chain dehydrogenase/reductase family 9C member 5) |
Synonyms | RDH1 HSD17B9 SDR9C5 |
Description | FUNCTION: Catalyzes the oxidation of cis-isomers of retinol, including 11-cis-, 9-cis-, and 13-cis-retinol in an NAD-dependent manner . Has no activity towards all-trans retinal (By similarity). Plays a significant role in 11-cis retinol oxidation in the retinal pigment epithelium cells (RPE). Also recognizes steroids (androsterone, androstanediol) as its substrates . . |
Accessions | ENST00000547072.5 F8VVC7 H0YHP7 ENST00000257895.10 F8VUB9 ENST00000552930.5 ENST00000548082.1 ENST00000548123.1 Q92781 |